<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>The Tightening Grip Of Big Pharmaceutical Companies</title><link>http://articles.mercola.com/sites/articles/archive/2001/05/02/pharmacy.aspx</link><description>When Prof Martin Cormican, a bacteriologist at University College Hospital, Ireland, wrote to Bayer in November last year asking for a supply of pure ciprofloxacin and related products for his research into antibiotic resistance, he was asked to sign</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>